Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on October 1, 2026

6 hours ago

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Indeterminate GlobeNewswire

6 hours ago

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio

Indeterminate GlobeNewswire

6 hours ago

Canadians Invited to “Carry the Weight” this October – For Kids Like Hamdiya

Indeterminate GlobeNewswire

6 hours ago

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Indeterminate GlobeNewswire

6 hours ago

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire

7 hours ago

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire

7 hours ago

RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals

Indeterminate GlobeNewswire

7 hours ago

Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies

Indeterminate GlobeNewswire

7 hours ago

Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

Indeterminate GlobeNewswire

8 hours ago

Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board

Indeterminate GlobeNewswire

9 hours ago

Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition

Indeterminate GlobeNewswire

9 hours ago

Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline

Indeterminate GlobeNewswire

9 hours ago

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

Indeterminate GlobeNewswire

9 hours ago

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Indeterminate GlobeNewswire

9 hours ago

Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Indeterminate GlobeNewswire

10 hours ago

SkinHealth Systems bringt das SkinStylus® SteriLock® MicroSystem auf den europäischen Markt

Indeterminate GlobeNewswire

10 hours ago

SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe

Indeterminate GlobeNewswire

10 hours ago

SkinHealth Systems anuncia el lanzamiento europeo de SkinStylus® SteriLock®

Indeterminate GlobeNewswire

10 hours ago

Le SkinStylus® SteriLock MicroSystem de SkinHealth Systems désormais disponible sur le marché européen

Indeterminate GlobeNewswire

11 hours ago

Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS

Indeterminate GlobeNewswire